# NRX Pharmaceuticals, Inc.: Regulation FD disclosure (Form 8-K, 2026-11-02)

**Trigger Strength Score:** 25/100

| Field | Value |
|---|---|
| Company | NRX Pharmaceuticals, Inc. |
| Ticker | NRXP |
| CIK | 1719406 |
| Filed | 2026-11-02 |
| Event date | 2026-10-30 |
| Primary trigger | Regulation FD disclosure |
| All items | 7.01 Regulation FD disclosure |
| Location | Wilmington, DE |
| SIC code | 2834 |
| Accession | 0001437749-26-034284 |

## Why this score
- Primary trigger: Regulation FD disclosure.
- Filed in the last 3 days.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1719406/000143774926034284/nrxp20261030_8k.htm). Last refreshed: 2026-11-04T09:16:40.251Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.